Keros Therapeutics (KROS) Announces Review of Strategic Alternatives
Go back to Keros Therapeutics (KROS) Announces Review of Strategic Alternatives| (NASDAQ: KROS) | Delayed: 11.20 +0.03 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.17 | 52 Week High | $ | |||
| Open | $11.25 | 52 Week Low | $ | |||
| Day High | $11.34 | P/E | N/A | |||
| Day Low | $11.17 | EPS | $ | |||
| Volume | 8,591 | |||||

